Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Loperamide in Patients with Intestinal Failure: Plasma Concentration and ECG Changes
2019-003172-40Phase 4Unknown
- Sponsor
- University Hospitals Plymouth
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of loperamide in intestinal failure (IF) and short bowel syndrome (SBS) (4 arms), sponsored by University Hospitals Plymouth. Primary endpoints: Plasma loperamide concentration, Plasma metabolite concentrations and 1 more. Status: unknown.
02
Drugs
loperamide
03
Conditions
intestinal failure (IF)short bowel syndrome (SBS)
Beyond the preview
Go deeper on 2019-003172-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003172-40.